Vaccination and Multiple Sclerosis – Current Situation

Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyko, A. N., Sivertseva, S. A., Chemakina, D. S., Spirin, N. N., Bykova, O. V., Guseva, M. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296221/
https://www.ncbi.nlm.nih.gov/pubmed/35875700
http://dx.doi.org/10.1007/s11055-022-01265-9
_version_ 1784750224568221696
author Boyko, A. N.
Sivertseva, S. A.
Chemakina, D. S.
Spirin, N. N.
Bykova, O. V.
Guseva, M. E.
author_facet Boyko, A. N.
Sivertseva, S. A.
Chemakina, D. S.
Spirin, N. N.
Bykova, O. V.
Guseva, M. E.
author_sort Boyko, A. N.
collection PubMed
description Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account of ongoing therapy and the nature of the course of illness. MS is not an absolute contraindication for vaccination against the new coronavirus infection. Vaccination can be with any of the currently authorized immunoformulations.
format Online
Article
Text
id pubmed-9296221
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-92962212022-07-20 Vaccination and Multiple Sclerosis – Current Situation Boyko, A. N. Sivertseva, S. A. Chemakina, D. S. Spirin, N. N. Bykova, O. V. Guseva, M. E. Neurosci Behav Physiol Article Active immunization of patients with autoimmune diseases is a current challenge. Vaccination of patients with multiple sclerosis (MS) has been shown not to be associated with increased risk of exacerbation. A personalized approach to immunization of this group of patients is required, taking account of ongoing therapy and the nature of the course of illness. MS is not an absolute contraindication for vaccination against the new coronavirus infection. Vaccination can be with any of the currently authorized immunoformulations. Springer International Publishing 2022-07-20 2022 /pmc/articles/PMC9296221/ /pubmed/35875700 http://dx.doi.org/10.1007/s11055-022-01265-9 Text en © Springer Nature Switzerland AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Boyko, A. N.
Sivertseva, S. A.
Chemakina, D. S.
Spirin, N. N.
Bykova, O. V.
Guseva, M. E.
Vaccination and Multiple Sclerosis – Current Situation
title Vaccination and Multiple Sclerosis – Current Situation
title_full Vaccination and Multiple Sclerosis – Current Situation
title_fullStr Vaccination and Multiple Sclerosis – Current Situation
title_full_unstemmed Vaccination and Multiple Sclerosis – Current Situation
title_short Vaccination and Multiple Sclerosis – Current Situation
title_sort vaccination and multiple sclerosis – current situation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296221/
https://www.ncbi.nlm.nih.gov/pubmed/35875700
http://dx.doi.org/10.1007/s11055-022-01265-9
work_keys_str_mv AT boykoan vaccinationandmultiplesclerosiscurrentsituation
AT sivertsevasa vaccinationandmultiplesclerosiscurrentsituation
AT chemakinads vaccinationandmultiplesclerosiscurrentsituation
AT spirinnn vaccinationandmultiplesclerosiscurrentsituation
AT bykovaov vaccinationandmultiplesclerosiscurrentsituation
AT gusevame vaccinationandmultiplesclerosiscurrentsituation

Ejemplares similares